TR201203086A2 - Sefiksim ve klavulanik asit içeren farmasötik dozaj formu. - Google Patents

Sefiksim ve klavulanik asit içeren farmasötik dozaj formu.

Info

Publication number
TR201203086A2
TR201203086A2 TR2012/03086A TR201203086A TR201203086A2 TR 201203086 A2 TR201203086 A2 TR 201203086A2 TR 2012/03086 A TR2012/03086 A TR 2012/03086A TR 201203086 A TR201203086 A TR 201203086A TR 201203086 A2 TR201203086 A2 TR 201203086A2
Authority
TR
Turkey
Prior art keywords
cefixime
clavulanic acid
dosage form
pharmaceutical dosage
clavulanic
Prior art date
Application number
TR2012/03086A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2012/03086A priority Critical patent/TR201203086A2/tr
Publication of TR201203086A2 publication Critical patent/TR201203086A2/tr

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, aktif ajan olarak sefiksim ve klavulanik asit ve/veya türevlerini içeren farmasötik bileşimlere ilişkindir.
TR2012/03086A 2010-05-14 2010-05-14 Sefiksim ve klavulanik asit içeren farmasötik dozaj formu. TR201203086A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2012/03086A TR201203086A2 (tr) 2010-05-14 2010-05-14 Sefiksim ve klavulanik asit içeren farmasötik dozaj formu.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2012/03086A TR201203086A2 (tr) 2010-05-14 2010-05-14 Sefiksim ve klavulanik asit içeren farmasötik dozaj formu.

Publications (1)

Publication Number Publication Date
TR201203086A2 true TR201203086A2 (tr) 2012-08-22

Family

ID=47004707

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2012/03086A TR201203086A2 (tr) 2010-05-14 2010-05-14 Sefiksim ve klavulanik asit içeren farmasötik dozaj formu.

Country Status (1)

Country Link
TR (1) TR201203086A2 (tr)

Similar Documents

Publication Publication Date Title
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
FI20145771L (fi) Parasitisidaalisia oraalisia eläinlääkekoostumuksia, jotka käsittävät systeemisesti vaikuttavan aktiiviaineen, menetelmiä ja käyttöjä
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
AR081681A1 (es) METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA
MX2013001677A (es) Formulaciones estables de linaclotida.
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
EA201201050A1 (ru) Пиразолы в качестве антагонистов crth2
EA201590805A1 (ru) Композиция с немедленным и пролонгированным высвобождением
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
UA115357C2 (uk) Похідні піридин-4-ілу
EA201400822A1 (ru) Производные гетероциклических амидов в качестве антагонистов p2xрецептора
CY1119064T1 (el) Ινωδολυτικες συνθεσεις οι οποιες περιεχουν βρωμελαϊνη και ναττοκιναση για την προληψη και αγωγη φλεβοθρομβωτικων καταστασεων
TR201009394A2 (tr) Geliştirilmiş montelukast formülasyonları.
UA109804C2 (xx) 2-метоксипіридин-4-ільні похідні
MX2019012375A (es) Formulaciones del inhibidor del antigeno-1 asociado a la funcion de linfocitos (lfa-1).
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
TR201109160A2 (tr) Eplerenon içeren yeni farmasötik kompozisyonlar.
TR201203086A2 (tr) Sefiksim ve klavulanik asit içeren farmasötik dozaj formu.
TR201009399A2 (tr) Hızlı çözünen efervesan rosuvastatin formülasyonları.
TR201203083A2 (tr) Sefdinir ve klavulanik asit içeren farmasötik dozaj formu.
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
TR201203087A2 (tr) Seftibüten ve klavulanik asit formülasyonları.
TR201203085A2 (tr) Sefetamet ve klavulanik asit içeren bileşimler.